Watch Ticker

CalAmp Corp.

Go to CalAmp Corp. Website

$1.72

0.07 (4.24%)

Live

Previous Close

$1.64

Day Range

$1.58 - $1.8199

Previous Day Range

$1.55 - $1.74

Market Cap

$33.3 million USD

Day Vol.

31306

Previous Day Vol.

75874

Currency

USD

Primary Exchange

Nasdaq

Camp4 Therapeutics Corp is a clinical stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Camp4 Therapeutics Corporation - CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual Meeting

CAMP4 presented positive data from its SYNGAP1-related disorders and urea cycle disorders programs, including increased protein levels in non-human primates and favorable safety data from a Phase 1 trial.

Related tickers: CAMP.

Read Full Article

Delveinsight - Angioedema Clinical Trial Pipeline Analysis Demonstrates 15+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

The angioedema treatment market is expected to grow due to the rising prevalence of allergic conditions and increasing awareness of hereditary angioedema (HAE). The pipeline analysis shows over 15 companies are developing 20+ angioedema drugs, with promising therapies in different clinical trial phases.

Related tickers: IONS, ATXS, NTLA, KALV, CAMP.

Read Full Article

Trending Tickers

Please sign in to view